Comparison of prevalence of metabolic syndrome in hospital and community-based Japanese patients with schizophrenia
Authors:
- Norio SugawaraNSNorio Sugawara
- Norio Yasui-FurukoriNYNorio Yasui-Furukori
- Yasushi SatoYSYasushi Sato
- Ikuko KishidaIKIkuko Kishida
- Hakuei YamashitaHYHakuei Yamashita
- Manabu SaitoMSManabu Saito
- Hanako FurukoriHFHanako Furukori
- Taku NakagamiTNTaku Nakagami
- Mitsunori HatakeyamaMHMitsunori Hatakeyama
- Sunao KanekoSKSunao Kaneko
Open Access
- 1 January 2011
- journal article
- research article
- Published by Springer Nature in Annals of General Psychiatry
- Vol. 10 (1) , 21
Abstract
Lifestyle factors, such as an unbalanced diet and lack of physical activity, may affect the prevalence of metabolic syndrome (MetS) in schizophrenic patients. The aim of this study was to compare the MetS prevalence between inpatients and outpatients among schizophrenic population in Japan. We recruited inpatients (n = 759) and outpatients (n = 427) with a Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) diagnosis of schizophrenia or schizoaffective disorder from 7 psychiatric hospitals using a cross-sectional design. MetS prevalence was assessed using three different definitions, including the adapted National Cholesterol Education Program Adult Treatment Panel (ATP III-A). The overall MetS prevalences based on the ATP III-A definition were 15.8% in inpatients and 48.1% in outpatients. In a logistic regression model with age and body mass index as covariates, being a schizophrenic outpatient, compared to being a schizophrenic inpatient, was a significant independent factor (odds ratio = 3.66 for males, 2.48 for females) in the development of MetS under the ATP III-A definition. The difference in MetS prevalence between inpatients and outpatients was observed for all age groups in males and for females over 40 years of age. Outpatients with schizophrenia or schizoaffective disorder in Japan had a high prevalence of MetS compared to inpatients. MetS in schizophrenic outpatients should be carefully monitored to minimize the risks. A change of lifestyle might improve MetS in schizophrenic patients.Keywords
This publication has 25 references indexed in Scilit:
- Metabolic profile of antipsychotic-naive individuals with non-affective psychosisThe British Journal of Psychiatry, 2009
- Gender differences in 542 Chinese inpatients with schizophreniaSchizophrenia Research, 2007
- Management of Antipsychotic-Induced Weight Gain: Prospective Naturalistic Study of the Effectiveness of a Supervised Exercise ProgrammeAustralian & New Zealand Journal of Psychiatry, 2007
- Effective cut-off values of waist circumference to detect the clustering of cardiovascular risk factors of metabolic syndrome in Japanese men and womenDiabetes & Vascular Disease Research, 2007
- How many long‐stay schizophrenia patients can be discharged in Japan?Psychiatry and Clinical Neurosciences, 2007
- Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes FederationDiabetic Medicine, 2006
- Diagnosis and Management of the Metabolic SyndromeCirculation, 2005
- Managing Atypical Antipsychotic–Associated Weight GainThe Journal of Clinical Psychiatry, 2004
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Age at onset of schizophrenia: Gender differences and influence of temporal socioeconomic changePsychiatry and Clinical Neurosciences, 2000